Ticker
EU approves extra corona-vaccine sites for Pfizer, Moderna
By EUobserver
Europe's medicines regulator has approved additional manufacturing sites for mRNA-based coronavirus vaccines developed by Pfizer-BioNTech and Moderna to help boost production amid a resurgence in infections, Reuters reports. The European Medicines Agency in Amsterdam said on Tuesday its human medicines committee had approved a site at Saint Remy sur Avre in France for making the Pfizer-BioNTech vaccine, Comirnaty.